Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 1

Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender

Authors Yvonne Koh, Fatimah Bte Moideen Kutty, Shu Chuen Li

Published 15 April 2005 Volume 2005:1(1) Pages 39—48

Yvonne Koh1, Fatimah Bte Moideen Kutty2, Shu Chuen Li1

1Department of Pharmacy, National University of Singapore, Republic of Singapore; 2Alexandra Hospital, Republic of Singapore

Background: Drug-related problems (DRPs) have been shown to prevail in hospitalized patients, and polypharmacy and increasing age have been identified as two important risk factors.

Objective: We investigated the occurrence of DRPs and adverse drug reactions (ADRs) amongst hospitalized patients prescribed polypharmacy, and the association of advanced age and female gender.

Method: A retrospective cross-sectional study was performed in an acute-care hospital in Singapore. Only patients prescribed polypharmacy were included. Mann-Whitney test was used to test for significant difference between the age and gender of patients and their risk of acquiring DRPs. The relative risks of developing DRP and ADR for geriatric patients and female patients were estimated.

Results: Of 347 patients prescribed polypharmacy (43% female and 58.2% geriatrics), no statistical correlations were observed between age and gender with developing DRPs. An increased number of medications was associated with higher risk for patients with DRPs on admission (p = 0.001), but not for inpatients with DRPs (p = 0.119). Results from patients with ADRs showed that the relative risk (RR) of geriatrics prescribed polypharmacy and major polypharmacy (10 and more drugs) were 1.01 and 1.23, respectively. Female patients had a RR of 0.79 compared with male patients in developing ADRs.

Conclusion: Results showed that among patients with polypharmacy, age and gender may not be as important as number of drugs prescribed as predictors of experiencing a DRP. A similar trend was observed in the development of ADRs.
Keywords: polypharmacy, drug-related problems, adverse drug reactions, geriatrics

 

Download Article [PDF] 

Readers of this article also read:

Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4

Shufeng Zhou, Eli Chan, Xiaotian Li, Min Huang

Therapeutics and Clinical Risk Management 2005, 1:3-13

Published Date: 15 April 2005

Should valproate be taken during pregnancy?

Mervyn J Eadie, Frank JE Vajda

Therapeutics and Clinical Risk Management 2005, 1:21-26

Published Date: 15 April 2005

Patient medication knowledge and adherence to asthma pharmacotherapy: a pilot study in rural Australia

Tabitha J Franks, Deborah L Burton, Maree D Simpson

Therapeutics and Clinical Risk Management 2005, 1:33-38

Published Date: 15 April 2005

Depression and drug utilization in an elderly population

Raffaele Antonelli Incalz, Andrea Corsonello, Claudio Pedone, Francesco Corica, Pierugo Carbonin

Therapeutics and Clinical Risk Management 2005, 1:55-60

Published Date: 15 April 2005

Principles in genetic risk assessment || FREE PAPER ||

Pedro Viana Baptista

Therapeutics and Clinical Risk Management 2005, 1:15-20

Published Date: 15 April 2005

Elective open abdominal aortic aneurysm repair: a seven-year experience

Stuart MacKenzie, judith R Swan, Cate D’Este,  Allan D Spigelman

Therapeutics and Clinical Risk Management 2005, 1:27-31

Published Date: 15 April 2005